This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paris, F. Articles by Sultan, C. Search for Related Content PubMed PubMed Citation Articles by Paris, F. Articles by Sultan, C.

A New Recombinant Cell Bioassay for Ultrasensitive Determination of Serum Estrogenic Bioactivity in Children

Unité INSERM 439 (F.P., N.S., B.T., P.B., J.C.N., C.S.), Pathologie Moléculaire des Récepteurs Nucléaires, Montpellier 34090, France; Service d’Hormonologie du Développement et de la Reproduction (F.P., C.S.), Hôpital Lapeyronie, 34295 Montpellier, France; and Unité d’Endocrinologie Pédiatrique (F.P., C.S.), Service de Pédiatrie 1, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France

Address all correspondence and requests for reprints to: Pr. Charles Sultan, INSERM U.439, Pathologie Moléculaire des Récepteurs Nucléaires, 60 rue de Navacelles, 34090 Montpellier, France. E-mail: chsultan{at}u439.montp.inserm.fr

Abstract

The evaluation of estrogenic status is necessary for many physiological and pathological conditions in pediatric as well as adult endocrinology. Because current immunoassays exclusively measure E2—and with a sensitivity that is insufficient for prepubertal children—we developed a new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity. This assay is based on human uterine cervix carcinoma cells, HeLa cells, that do not naturally express E2 receptor. These cells were transfected with plasmids encoding the human ER or ß, along with an estrogen-responsive promoter fused to the luciferase gene, and called HELN and HELNß for HeLa estrogen-responsive element luciferase neomycin and ß. HELN and HELNß are able to respond to estrogens and various compounds having estrogenic activity but, because of the importance of ER in the reproductive function, we chose to work with the HELN cell line. The luciferase activity we obtained was compared with an E2 standard curve specific for each serum sample and established with stripped serum. The estrogenic bioactivity was expressed in picograms of E2 equivalents, and the detection limit was < 1 pg·ml^-1 E2 equivalents. The intra and interassay error was lower than 10% and 20%, respectively. We measured estrogenic bioactivity in 18 normal prepubertal boys (age = 9.7 ± 2.4 yr), 18 normal prepubertal girls (age = 9.2 ± 1.7 yr) and 18 normal pubertal girls (age = 13.6 ± 1.8 yr). The estrogenic bioactivity in the prepubertal girls was significantly higher than in the boys, i.e. 3.53 ± 2.23 pg·ml^-1 vs. 1.44 ± 0.87 pg·ml^-1 (P < 0.01). A significant difference was found between the pre- and pubertal girls, i.e. 3.53 ± 2.23 pg·ml^-1 vs. 26.77 ± 18.32 pg·ml^-1 (P < 0.01). This ultrasensitive bioassay measures total estrogenic bioactivity of serum with very high sensitivity. It has numerous potential applications in pediatric and adult endocrinology. In addition, this assay may help to evaluate excess estrogenic activity related to aromatase overexpression or contamination by environmental chemicals.

This article has been cited by other articles:

				C. Ankarberg-Lindgren, E. Norjavaara, M. M. Kushnir, W. L. Roberts, A. L. Rockwood, J. Bergquist, A. M. Bunker, and A. W. Meikle Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children? Am J Clin Pathol, May 1, 2009; 131(5): 746 - 750. [Full Text] [PDF]

				C. Ankarberg-Lindgren and E. Norjavaara A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17 -estradiol in prepubertal children Eur. J. Endocrinol., January 1, 2008; 158(1): 117 - 124. [Abstract] [Full Text] [PDF]

				P. Roy, M. Alevizaki, and I. Huhtaniemi In vitro bioassays for androgens and their diagnostic applications Hum. Reprod. Update, January 1, 2008; 14(1): 73 - 82. [Abstract] [Full Text] [PDF]

				L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson The sensitivity of the child to sex steroids: possible impact of exogenous estrogens Hum. Reprod. Update, July 1, 2006; 12(4): 341 - 349. [Abstract] [Full Text] [PDF]

				S. Wang, F. Paris, C. S. Sultan, R. X.-D. Song, L. M. Demers, B. Sundaram, J. Settlage, S. Ohorodnik, and R. J. Santen Recombinant Cell Ultrasensitive Bioassay for Measurement of Estrogens in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1407 - 1413. [Abstract] [Full Text] [PDF]

				E. Sonneveld, H. J. Jansen, J. A. C. Riteco, A. Brouwer, and B. van der Burg Development of Androgen- and Estrogen-Responsive Bioassays, Members of a Panel of Human Cell Line-Based Highly Selective Steroid-Responsive Bioassays Toxicol. Sci., January 1, 2005; 83(1): 136 - 148. [Abstract] [Full Text] [PDF]

				T. Raivio, L. Dunkel, S. Wickman, and O. A. Janne Serum Androgen Bioactivity in Adolescence: A Longitudinal Study of Boys with Constitutional Delay of Puberty J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1188 - 1192. [Abstract] [Full Text] [PDF]

				G. Guercio, M. A. Rivarola, E. Chaler, M. Maceiras, and A. Belgorosky Relationship between the Growth Hormone/Insulin-Like Growth Factor-I Axis, Insulin Sensitivity, and Adrenal Androgens in Normal Prepubertal and Pubertal Girls J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1389 - 1393. [Abstract] [Full Text] [PDF]